Ponatinib-induced pneumonitis with severe acute respiratory distress syndrome

Ponatinib-induced pneumonitis with severe acute respiratory distress syndrome

Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) that can effectively treat patients with acute lymphoblastic leukaemia (ALL), particularly those with Philadelphia chromosome-positive (Ph+ALL) subtype, who are resistant or have previously received other TKIs. We report a case of a 42-...

Full description

Bibliographic Details
Main Authors: Sofia Dinis Ferreira, Margarida Jardim, Margarida Câmara, Fernando Jacinto, Fernando Aveiro, José Júlio Nóbrega
Format: Article
Language:English
Published: SMC MEDIA SRL 2023-11-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
ponatinib
acute lymphoblastic leukaemia
philadelphia chromosome-positive
ards
pneumonitis
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/4162

Similar Items

Similar Items